Contraindication

A contraindication is a medical, pharmacological, or physiological circumstance that shifts the risk–benefit balance of a substance against use. The term originates in clinical medicine, where it signals not a moral stance but an evidence-based assessment: for a given person in a given state, the expected harm exceeds the expected benefit.

The distinction between kinds matters in practice. An absolute contraindication means the risk is judged severe enough that no expected benefit justifies exposure. A relative contraindication means the balance sits against use, but a specific clinical reason could tip it back — the risk is elevated, not categorical.

How it is done

Identifying contraindications means comparing what a substance does pharmacologically against what a person brings to it: their health status, existing medications, and relevant circumstances such as pregnancy, age, or organ function.

In clinical settings this happens through a structured medication review — a prescribing reference, interaction database, and documented organ-specific risks, weighed by a practitioner against the individual case. Outside clinical settings, the same published information is available but without a practitioner to apply it.

The practice requires knowing both sides. A substance metabolised primarily by the liver carries different implications for someone with hepatic impairment. One that constricts airways has different stakes in someone whose baseline airflow is already reduced. The relevant question is not whether a risk exists in the abstract, but whether the individual's circumstances amplify it.

What it cannot tell you

Knowing a contraindication exists does not quantify how much added risk it represents. The research generating contraindication guidance typically comes from controlled patient populations — not the doses, combinations, or contexts common to non-clinical use. For many substance–condition pairs, the evidence base is thin or absent.

The absence of a listed contraindication is not a finding of safety. A condition may not have been studied against a given substance. A concurrent drug may have no documented interaction simply because the combination has never been assessed. The published guidance reflects what was known when it was written, not the full range of possible interactions.

The wrong conclusion a clear record most readily produces is that use is appropriate because nothing in the literature flags it. What that result means is that no documented contraindication was identified — a narrower statement that leaves unstudied interactions, individual variation, and undisclosed health conditions entirely outside its reach.